First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 745 000 KRW -1.32%
Updated: May 29, 2024

Samsung Biologics Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Samsung Biologics Co Ltd
Total Current Assets Peer Comparison

Comparables:
P
087010
S
237690
F
220100
L
141080
C
268600

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Total Current Assets
₩5.6T
CAGR 3-Years
46%
CAGR 5-Years
30%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Total Current Assets
₩11.2B
CAGR 3-Years
-46%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Total Current Assets
₩348.4B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Total Current Assets
₩31.3B
CAGR 3-Years
-14%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Total Current Assets
₩134.6B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
20%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Total Current Assets
₩29.6B
CAGR 3-Years
1%
CAGR 5-Years
34%
CAGR 10-Years
N/A

See Also

What is Samsung Biologics Co Ltd's Total Current Assets?
Total Current Assets
5.6T KRW

Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Total Current Assets amounts to 5.6T KRW.

What is Samsung Biologics Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
30%

Over the last year, the Total Current Assets growth was -8%. The average annual Total Current Assets growth rates for Samsung Biologics Co Ltd have been 46% over the past three years , 30% over the past five years .